November 6, 2021
Avicanna Announces Management Change
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
Pharmaceuticals, Biotechnology and Life Sciences
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
Bagsværd, Denmark, 5 November 2021 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by…
Presentation to focus on potential use of AT-1501 in kidney transplantation as well as research collaboration between Eledon and CareDx…
First nine months 2021 financial results: Group revenues of €317.9 millionOperating loss of €175.7 millionNet loss of €119.6 millionCash and…
• Sponsored programs at ASH 2021 – preliminary clinical data to be presented at ASH 2021 for product candidate UCART22…
BERKELEY, Calif. and MAINZ, Germany, Nov. 04, 2021 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October…
Announces clinical collaboration with Roche for first line NSCLC Remains on track with clinical data milestone timing BOSTON, Nov. 04,…
WALTHAM, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…
Company Announcement Genmab improves its 2021 financial guidance COPENHAGEN, Denmark; November 4, 2021 – Genmab A/S (Nasdaq: GMAB) announced today…